DAM
PSTX

Deltec Asset Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Deltec Asset Management’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-150,000
Closed -$1.44M – 186
2024
Q4 		$1.44M Buy
+150,000
New +$783K 0.28% 57

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Deltec Asset Management's PSTX Position: Q1 2025 in Review

Deltec Asset Management sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 150,000 shares — an estimated $1.44M sold.

Deltec Asset Management first reported a position in PSTX in Q4 2024 and held it in 1 quarter. The position peaked at $1.44M in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • Deltec Asset Management reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Deltec Asset Management sold 150,000 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $1.44M.
  • Deltec Asset Management first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
  • Deltec Asset Management's Poseida Therapeutics, Inc. Common Stock position peaked at $1.44M in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Deltec Asset Management's 13F filing for Q1 2025, filed 22 Apr 2025.